Clinical trial
The Effect of Obesity on the Pharmacokinetics of Pantoprazole and CYP2C19 Activity in Children and Adolescents With GERD
NCT01887743 is registered in ClinicalTrials.gov with Children's Mercy Hospital Kansas City as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Obesity on the Pharmacokinetics of Pantoprazole and CYP2C19 Activity in Children and Adolescents With GERD
- Lead sponsor
- Children's Mercy Hospital Kansas City
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 30, 2013
- Completion date
- October 31, 2015
- Enrollment
- 71 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gerd, obesity